Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Acquisition
Acquisition of balance 12,00,000 Equity Shares (representing 15% paid up equity share capital) of Getwell Medicare Solution Private Limited, the subsidiary company, from the erstwhile promoters. Entero Healthcare Solutions Ltd - 544122 - Board Meeting Outcome for Outcome Of Board Meeting Held On March 08, 2024
Outcome of Board Meeting held on March 08, 2024 Entero Healthcare Solutions Ltd - 544122 - Submission Of Financial Results For The Quarter And Nine Months Ended December 31, 2023
Submission of Financial Results for the Quarter and Nine Months ended December 31, 2023 Entero Healthcare Solutions Ltd - 544122 - Submission Of Financial Results For The Quarter And Nine Months Ended December 31, 2023
Submission of Financial Results for the Quarter and Nine Months ended December 31, 2023 Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Registration link of the Earnings call on financial results for the Quarter and Nine Months ended December 31, 2023 Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Earnings call on financial results for the Quarter and Nine Months ended December 31, 2023 Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for GIC Pvt Ltd Entero Healthcare Solutions Ltd - 544122 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Friday, March 08, 2024.
Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31, 2023. Entero Healthcare Solutions Ltd - 544122 - Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Temporarily suspended the drug license of CPD Pharma Private Limited, a wholly owned Subsidiary of the Company, for a period of seven days from 26.02.2024 to 03.03.2024. Entero Healthcare Solutions Ltd - 544122 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd